177A.T

Aug 14, 2026, 06:00 UTC

Kojin Bio reported a consolidated ordinary loss of 36 million yen for the first quarter of fiscal year ending March 2027 (April-June 2026), swinging from a profit of 116 million yen in the same period last year.